Source: Mediators of Inflammation. Unidades: FM, ICB
Subjects: FISIOLOGIA, IMUNOLOGIA, GLICEMIA, LEUCOTRIENOS, SISTEMA NERVOSO AUTÔNOMO, NEUROPATIAS DIABÉTICAS, DIABETES MELLITUS, EXPRESSÃO GÊNICA, NEFROPATIAS, INFLAMAÇÃO
ABNT
BEZERRA, Daniele Perreira dos Santos et al. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/5704713. Acesso em: 26 ago. 2024.APA
Bezerra, D. P. dos S., Ribeiro Junior, L. F., Monteiro, M. B., Admoni, S. N., Perez, R. V., Cavaleiro, A. M. de S., et al. (2020). Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes. Mediators of Inflammation, 9 . doi:10.1155/2020/5704713NLM
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2024 ago. 26 ] Available from: https://doi.org/10.1155/2020/5704713Vancouver
Bezerra DP dos S, Ribeiro Junior LF, Monteiro MB, Admoni SN, Perez RV, Cavaleiro AM de S, Machado CG, Machado UF, Passarelli M, Jancar S, Giannella MLC. Leukotriene pathway activation associates with poor glycemic control and with cardiovascular autonomic neuropathy in type 1 diabetes [Internet]. Mediators of Inflammation. 2020 ; 9 .[citado 2024 ago. 26 ] Available from: https://doi.org/10.1155/2020/5704713